Join the Parkinson's Disease group to help and get support from people like you.
Parkinson's Disease News
Related terms: Parkinson's
Common Medications Tied to Older Age at Onset of Parkinson Disease
FRIDAY, April 25, 2025 – Multiple common medications are associated with a considerable delay of Parkinson disease (PD) symptom onset, according to a study published online March 6 in the Journal of...
Common Meds Appear To Delay Onset Of Parkinson's Disease
THURSDAY, April 17, 2025 – Common medications like aspirin, ibuprofen, statins and beta blockers appear to slow the progress of Parkinson’s disease, a new study says. Parkinson’s symptoms took nea...
AAN: Tavapadon as Adjunct to Levodopa Ups Daily ON Time in Parkinson Disease
TUESDAY, April 8, 2025 – For patients with Parkinson disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases...
Globally, 25.2 Million Projected to Be Living With Parkinson Disease in 2050
MONDAY, March 10, 2025 – The prevalence of Parkinson disease is projected to increase through 2050, according to a study published online March 5 in The BMJ. Using data from the Global Burden of...
Parkinson's Cases Expected To Double In Coming Decades
FRIDAY, March 7, 2025 – The number of people with Parkinson’s disease will more than double by 2050, driven by the aging of the global population, a new study suggests. In all, 25.2 million people w...
AAN: Obstructive Sleep Apnea Linked to Increased Incidence of Parkinson Disease
TUESDAY, March 4, 2025 – Obstructive sleep apnea (OSA) is associated with an increased risk for Parkinson disease (PD), according to a study scheduled for presentation at the annual meeting of the...
FDA Approves Onapgo (apomorphine hydrochloride) for the Treatment of Motor Fluctuations in Adults with Advanced Parkinson’s Disease
ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) – Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of...
Study Finds Exenatide Not Beneficial for Parkinson Disease
FRIDAY, Feb. 7, 2025 – The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity, according to a study published online Feb. 4 in...
FDA Approves Wearable Infusion Device for Advanced Parkinson Disease
THURSDAY, Feb. 6, 2025 – The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the...
Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds
WEDNESDAY, Feb. 5, 2025 – Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit. A new study found that a drug in the same class called exenatide,...
Hearing Impairment Tied to Higher Risk for New Parkinson Disease Diagnosis
TUESDAY, Jan. 21, 2025 – Hearing impairment is a risk factor for incident Parkinson disease (PD), according to a study published online in the February issue of Parkinsonism and Related Disorders....
Dancing Helps People With Parkinson’s In More Ways Than One
MONDAY, Dec. 23, 2024 – Dancing appears to lift the spirits of people with Parkinson’s disease. Depression eased in Parkinson’s patients who took months of dance classes, a new study published rec...
Early Research Points to Possible New Parkinson's Drug
THURSDAY, Dec. 19, 2024 – Parkinson's is a relentless disease for which few treatments, and no real cure, exists. Now, researchers say they are on the trail of a potential new therapy for the...
Multiple Penicillin Courses Linked to Modestly Lower Risk for Parkinson Disease
MONDAY, Nov. 4, 2024 – Adults who have received multiple penicillin courses have a modestly lower risk for Parkinson disease (PD), according to a study published in the October issue of Parkinsonism...
Costs for MS, Parkinson's and Alzheimer's Meds Keep Rising
THURSDAY, Oct. 31, 2024 – A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that same patient spent $2,378 annually, a new report...